Perspective · 10 Sep 2026
Research articlePublished 23 Dec 2022
Immune-Modulating Effects of Mycobacteria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Several species of Mycobacterium have been identified as having the ability to modulate immune responses, even as heat-killed preparations. Our goal was to identify mycobacteria that could potentially act in a safe and non-toxic immune-modulating effect by promoting the production of specific chemokine and cytokine responses with a potential application for impacting the microbiome. We relied on the following Mycobacterium strains: M. smegmatis, M. agri, M. phlei, M. tokaiense, M. brumae, M. aurum, and M. obuense. M. smegmatis and M. agri were the most effective in inducing immune responses in cultured Peripheral Blood Mononuclear Cells (PBMC) manifested by extracellular productions of the cytokine IL-6, as well as the chemokines IL-8, MIP-1α and MIP-1β. Correlation analyses and immune challenges to the bacterial mixtures showed that while cytokine and chemokine responses to M. smegmatis and M. agri were similar, they were distinct from responses to either B. subtilis or Phyto-Hemagglutinin (PHA) suggesting that Mycobacterium strains and B. subtilis have different effects on the immune system. Our methodology for comparing immune responses of bacterial preparations may provide a useful tool for studying immune effects of pathogenic and non-pathogenic bacteria. Distinct immune-modulatory properties of multiple species may have potential implications for immunotherapy of cancer as well as treatments of various immune-deficiency disorders.
Keywords
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Bruce S. Gillis”

